SCHEMBL1250495

SCHEMBL1250495

C#Cc1ccc(-c2nc3sccn3c2NC(C)(C)C)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.58
GAA P10253 9/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GFER P55789 1/20 0.40
MAPT P10636 8/20 0.35
POLB P06746 2/20 0.35
HSD17B10 Q99714 1/20 0.35
TP53 P04637 2/20 0.35
ADRA1B P35368 1/20 0.33
TRPA1 O75762 1/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252663 0.85 IDO1 (0.55) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1253098 0.84 IDO1 (0.57) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1252727 0.83 IDO1 (0.63) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1251906 0.83 IDO1 (0.52) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1252774 0.83 IDO1 (0.55) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1250432 0.83 IDO1 (0.52) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1250420 0.80 IDO1 (0.54) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL5116403 0.79 ADRA1B (0.58) GAAKDM4EALDH1A1GFERMAPT
SCHEMBL1252798 0.79 IDO1 (0.50) IDO1GAAKDM4EALDH1A1GFER
SCHEMBL1252644 0.79 IDO1 (0.50) IDO1GAAKDM4EALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996596-B1 SUBSTITUTED IMIDAZO(2,1-B)THIAZOLE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2015-07-08 EP disclosed
US-7893069-B2 Substituted imidazo[2,1-b]thiazole compounds and uses thereof GRUENENTHAL GMBH (DE) 2011-02-22 US disclosed
US-20090005399-A1 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof GRUENENTHAL GMBH (DE) 2009-01-01 US disclosed
EP-1996596-A2 SUBSTITUTED IMIDAZO(2,1-B)THIAZOLE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-12-03 EP disclosed
WO-2007104485-A2 SUBSTITUTED IMIDAZO[2,1-B]THIAZOLE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005399-A1 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof GRM5, GRIK5, GRM1 IDO1 3418/4885GAA 4187/4885KDM4E 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.